TherapeuticsMD

TXMDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$25.001 M

$2.16 +2.86%

Close of 22 Sept 2026

Revenue

$1.76M

#3434 by revenue

Earnings

-$569.0K

Loss-making

Shares outstanding

11,574,362

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#383Optimi HealthOPTH$28.4M
#384GridAI TechnologiesGRDX$27.7M
#385TherapeuticsMDTXMD$25.0M
#386Aytu BiopharmaAYTU$23.9M
#387Radiopharm TheranosticsRADX$23.9M

What if TherapeuticsMD were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,612,150

Per share 1,209,329× higher

Bitcoin $1.74T

$150,475.25

Per share 69,664× higher

Nvidia $5.52T

$476,550.41

Per share 220,625× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for TherapeuticsMD are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.